These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28810127)

  • 21. Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies - United States, 2007-2014.
    Faul M; Bohm M; Alexander C
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(12):320-323. PubMed ID: 28358791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.
    Kim TW; Walley AY; Heeren TC; Patts GJ; Ventura AS; Lerner GB; Mauricio N; Saitz R
    J Subst Abuse Treat; 2017 Oct; 81():1-10. PubMed ID: 28847449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients.
    Garg RK; Fulton-Kehoe D; Franklin GM
    Med Care; 2017 Jul; 55(7):661-668. PubMed ID: 28614178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.
    Stein BD; Mendelsohn J; Gordon AJ; Dick AW; Burns RM; Sorbero M; Shih RA; Liccardo Pacula R
    J Addict Dis; 2017; 36(1):14-22. PubMed ID: 27449904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of overdose on health plan disenrollment among patients prescribed long-term opioids: Retrospective cohort study.
    Fenton JJ; Magnan EM; Tancredi DJ; Tseregounis IE; Agnoli AL
    Drug Alcohol Depend; 2024 May; 258():111277. PubMed ID: 38581921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic opioid use in a health-insured epilepsy population during 2012.
    Wilner AN; Sharma BK; Thompson AR; Krueger A
    Epilepsy Behav; 2016 Apr; 57(Pt A):126-132. PubMed ID: 26949154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overdose deaths involving prescription opioids among Medicaid enrollees - Washington, 2004-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(42):1171-5. PubMed ID: 19875978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries.
    Mark TL; Parish WJ; Zarkin GA
    JAMA Netw Open; 2020 Apr; 3(4):e203132. PubMed ID: 32310285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization.
    Petrilla A; Marrett E; Shen X; Kwong WJ; Pezalla E
    Am Health Drug Benefits; 2020 Feb; 13(1):21-31. PubMed ID: 32165996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.
    Naumann RB; Roberts AW; Marshall SW; Skinner AC
    Med Care; 2019 Mar; 57(3):213-217. PubMed ID: 30629016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study.
    Lo-Ciganic WH; Donohue JM; Yang Q; Huang JL; Chang CY; Weiss JC; Guo J; Zhang HH; Cochran G; Gordon AJ; Malone DC; Kwoh CK; Wilson DL; Kuza CC; Gellad WF
    Lancet Digit Health; 2022 Jun; 4(6):e455-e465. PubMed ID: 35623798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults.
    Kuo YF; Raji MA; Goodwin JS
    JAMA Netw Open; 2019 Nov; 2(11):e1915638. PubMed ID: 31730188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid use disorder and overdose among youth following an initial opioid prescription.
    Hadland SE; Bagley SM; Gai MJ; Earlywine JJ; Schoenberger SF; Morgan JR; Barocas JA
    Addiction; 2021 Oct; 116(10):2790-2800. PubMed ID: 33739476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
    Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
    J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
    Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
    J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
    J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.